The U.S. Food and Drug Administration today approved expanded use of Vonvendi [von Willebrand factor (Recombinant)] for routine preventative (prophylactic) use in adults (age 18 years and older) with all types of von Willebrand disease (VWD) and on-demand and treatment of bleeding episodes and perio
Similar Posts
CSL Behring – 716297 – 09/09/2025
Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)Sno Pac Foods Recalls Del Mar 35 LB Bulk Frozen Spinach and 10 oz Organic Frozen Cut Spinach
Sno Pac Foods of Caledonia, MN, is recalling Del Mar 35 LB Bulk Organic Frozen Spinach and Sno Pac10 oz Organic Frozen Cut Spinach because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious or sometimes fatal infections in young children, fraiCDL Services, Inc. DBA Technichem – 713877 – 11/24/2025
CGMP/Finished Pharmaceuticals/AdulteratedOlympus Expands Voluntary Recall for ViziShot 2 FLEX (19G) EBUS -TBNA Needles
CENTER VALLEY, Pa., (January 16, 2026) — Olympus Corporation has announced the expansion of a previous global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) after receiving and investigating complaints of device components ejecting or detaching duringAdvisory Letters
Advisory Letterscheaptrustedpharmacy.com – 705501 – 07/29/2025
Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet